Bacterial lipopolysaccharide-induced hyporeactivity in perfused rat resistance vessels: modulating effects of dexamethasone

The present study was carried out on mesenteric vascular bed from LPS-injected rats in order to investigate possible mechanisms underlying hyporesponsiveness in resistance blood vessels in the course of septic shock syndrome. The involvement of L-arginine (L-Arg)/nitric oxide (NO) pathway was evaluated by administration of L-Arg, which produced a decrease in perfusion pressure in LPS-treated rats, whereas it was ineffective in control rats. Of note, dexamethasone (DEX) pretreatment in endotoxaemic rats significantly reduced the vasorelaxation by L-Arg; however, this non selective inhibitor of inducible-NOS expression was not able to prevent noradrenaline (NA) hyporeactivity. Furthermore, in order to evaluate whether hyporesponsiveness could be due to an altered contraction mechanism, the effect of endothelin (ET)-1 was tested. This peptide was able to markedly enhance the contractile response to noradrenaline in LPS-treated rats. Collectively, our findings suggest that vascular hyporesponsiveness during septic shock can only be partially explained by activation of the L-Arg/NO pathway. Other mechanisms, probably related to smooth muscle cell contractility, may be involved.

[1]  M. Serio,et al.  L-ARG/NO pathway contributes to LPS-induced hyporeactivity in rat mesenteric vascular bed: Effect of no-synthase inhibitors , 1995 .

[2]  S. Moncada,et al.  Effects of a nitric oxide synthase inhibitor in humans with septic shock. , 1994, Cardiovascular research.

[3]  I. Fleming,et al.  Effect of dexamethasone on the onset and persistence of vascular hyporeactivity induced by E. coli lipopolysaccharide in rats. , 1993, Circulatory shock.

[4]  S. Moncada,et al.  The role of nitric oxide in endothelial cell damage and its inhibition by glucocorticoids , 1992, British journal of pharmacology.

[5]  S. Moncada,et al.  Protective and pathological roles of nitric oxide in endotoxin shock. , 1992, Cardiovascular research.

[6]  I. Fleming,et al.  Inducible but not constitutive production of nitric oxide by vascular smooth muscle cells. , 1991, European journal of pharmacology.

[7]  J. Parratt,et al.  Evidence that an l‐arginine/nitric oxide dependent elevation of tissue cyclic GMP content is involved in depression of vascular reactivity by endotoxin , 1991, British journal of pharmacology.

[8]  J. Parratt,et al.  The effect of inhibitors of the l‐arginine/nitric oxide pathway on endotoxin‐induced loss of vascular responsiveness in anaesthetized rats , 1991, British journal of pharmacology.

[9]  J. Parratt,et al.  Activation of the l arginine nitric oxide pathway is involved in vascular hyporeactivity induced by endotoxin , 1991 .

[10]  S. Moncada,et al.  Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects on vascular tone: an insight into endotoxin shock. , 1990, Biochemical and biophysical research communications.

[11]  S. Moncada,et al.  Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[12]  J. Parratt,et al.  Loss of vascular responsiveness induced by endotoxin involves L-arginine pathway. , 1990, The American journal of physiology.

[13]  J. Parratt,et al.  Incubation with endotoxin activates the L-arginine pathway in vascular tissue. , 1990, Biochemical and biophysical research communications.

[14]  S. Douglas,et al.  Endothelium‐dependent vascular activities of endothelin‐like peptides in the isolated superior mesenteric arterial bed of the rat , 1990, British journal of pharmacology.

[15]  E. Reynolds,et al.  Role of thromboxane A2/prostaglandin H2 receptor in the vasoconstrictor response of rat aorta to endothelin. , 1990, The Journal of pharmacology and experimental therapeutics.

[16]  S. Moncada,et al.  A specific inhibitor of nitric oxide formation from l‐arginine attenuates endothelium‐dependent relaxation , 1989, British journal of pharmacology.

[17]  B. Roth,et al.  Alterations in rat aortic alpha 1-adrenoceptors and alpha 1-adrenergic stimulated phosphoinositide hydrolysis in intraperitoneal sepsis. , 1988, Circulatory shock.

[18]  A. Mandich,et al.  Angiotensin II vascular receptors in fetal and neonatal rats , 1988, Cell biochemistry and function.

[19]  I. Wakabayashi,et al.  Diminution of contractile response of the aorta from endotoxin-injected rats. , 1987, European journal of pharmacology.

[20]  B. Roth,et al.  Pharmacologic manipulation of the peripheral vasculature in shock: clinical and experimental approaches. , 1986, Circulatory shock.

[21]  K. Müller,et al.  Endothelial cell loss enhances the pressor response in resistance vessels. , 1984, Journal of Hypertension - Supplement.

[22]  P. Kadowitz,et al.  Studies on the mechanism of hydrocortisone potentiation of vasoconstrictor responses to epinephrine in the anesthetized animal , 1972 .

[23]  J. Laragh,et al.  Angiotensin II vascular receptors: their avidity in relationship to sodium balance, the autonomic nervous system, and hypertension. , 1972, The Journal of clinical investigation.